cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Neximmune Inc
3 own
7 watching
Current Price
$0.43
$0.02
(4.55%)
logo-nexi
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
11.09M
52-Week High
52-Week High
4.91
52-Week Low
52-Week Low
0.1947
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization11.09M
icon52-Week High4.91
icon52-Week Low0.1947
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio--
What does the Neximmune Inc do?
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company s product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Read More
How much money does Neximmune Inc make?
News & Events about Neximmune Inc.
PR Newswire
4 months ago
Thinking about buying stock in Neximmune, ShiftPixy, IN8BIO, Relay Therapeutics, or Reata Pharmaceuticals? Thinking about buying stock in Neximmune, ShiftPixy, IN8BIO, Relay Therapeutics, or Reata Pharmaceuticals? PR Newswire NEW YORK, Sept. 8, 2022 NEW YORK, Sept. 8, 2022 /PRNewswire...
PR Newswire
6 months ago
Thinking about buying stock in Allogene Therapeutics, Neximmune, Vertical Aerospace, Sonim Technologies, or DigitalBridge? Thinking about buying stock in Allogene Therapeutics, Neximmune, Vertical Aerospace, Sonim Technologies, or DigitalBridge? PR Newswire NEW YORK, July 15, 2022 NEW YORK, July...
Benzinga
10 months ago
The Dow Jones jumped around 200 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor...
Benzinga
10 months ago
read more...
Benzinga
10 months ago
Gainers Hycroft Mining Holding Corporation (NASDAQ: HYMC) shares jumped 138.1% to close at $1.50 on Thursday after dropping 37% on Wednesday. read more...
Frequently Asked Questions
Frequently Asked Questions
What is Neximmune Inc share price today?
plus_minus_icon
Can Indians buy Neximmune Inc shares?
plus_minus_icon
How can I buy Neximmune Inc shares from India?
plus_minus_icon
Can Fractional shares of Neximmune Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Neximmune Inc stocks?
plus_minus_icon
What is today’s traded volume of Neximmune Inc?
plus_minus_icon
What is today’s market capitalisation of Neximmune Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Neximmune Inc?
plus_minus_icon
What percentage is Neximmune Inc down from its 52-Week High?
plus_minus_icon
What percentage is Neximmune Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0.43
$0.02
(4.55%)
logo-nexi
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00